title: The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.
abstract: The vascular and parenchymal amyloid deposits in Alzheimer disease (AD), normal aging and Down syndrome are mainly composed of a 4 kDa polypeptide (A4), which derives from a larger precursor protein (APP). There is evidence that APP is a transmembrane glycoprotein present in most tissues, but the characteristics of APP in intact cells are not yet known. In order to investigate this issue, we examined the immunoreactivity of fibroblasts of human and nonhuman cell lines with antisera raised to synthetic peptides corresponding to A4 and to two other domains of the APP. All three antisera recognized a 130 kDa polypeptide (APP-130) in immunoblots from all cell lines. In fibroblasts, an additional polypeptide of 228 kDa (APP-228) was recognized by the antiserum to A4. In immunoblots of two dimensional gels, APP-130 showed a pI of 6.2, while APP-228 failed to focus in the pH range of 4.7-7.0. Sequential extractions of cells with buffer and with Triton X-100 indicate that APP-130 is extractable with nonionic detergents at high ionic strength, whereas 228 kDa APP is a cystolic component. Immunofluorescence staining is consistent with an intracellular perinuclear and plasma membrane localization. It is concluded that APP-130 and APP-228 are two forms of the APP which result from extensive posttranslational modifications of a smaller original gene product. It is likely that APP undergoes similar posttranslational modifications in different cell types.
authors.affiliation: Division of Neuropathology, Case Western Reserve University, Cleveland, OH 44106.
authors.forename: L
authors.initials: L
authors.lastname: Autilio-Gambetti
authors.forename: A
authors.initials: A
authors.lastname: Morandi
authors.forename: M
authors.initials: M
authors.lastname: Tabaton
authors.forename: B
authors.initials: B
authors.lastname: Schaetzle
authors.forename: D
authors.initials: D
authors.lastname: Kovacs
authors.forename: G
authors.initials: G
authors.lastname: Perry
authors.forename: S
authors.initials: S
authors.lastname: Sharma
authors.forename: J
authors.initials: J
authors.lastname: Cornette
authors.forename: B
authors.initials: B
authors.lastname: Greenberg
authors.forename: P
authors.initials: P
authors.lastname: Gambetti
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D000682:Amyloid / Q000096:biosynthesis*; D016564:Amyloid beta-Protein Precursor; D002478:Cells, Cultured; D004591:Electrophoresis, Polyacrylamide Gel; D005347:Fibroblasts / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D007106:Immune Sera; D015151:Immunoblotting; D011498:Protein Precursors / Q000096:biosynthesis*
chemical_list: D000682:Amyloid; D016564:Amyloid beta-Protein Precursor; D007106:Immune Sera; D011498:Protein Precursors